We have shown previously in murine breast and lung cancer models 34, and confirmed in the present mouse sarcoma model, that PLAD retains a level of tumor doxorubicin delivery similar to PLD despite increased uptake in spleen. This evidence concerns the gene GPLD1 and lung carcinoma.